New GCP regimen for clinical pharmacology studies in Argentina
This article was originally published in SRA
Argentina's National Medicines, Food and Medical Technology Administration, ANMAT, has updated its previous rules concerning good clinical practices in clinical pharmacology studies1.
You may also be interested in...
ANMAT, Argentina's drug and healthcare products regulatory agency, has issued a regulation establishing the minimum requirements that companies need to follow in order to switch their product from prescription-only to over-the-counter status1.
Argentina's National Medicines, Food and Medical Technology Administration, ANMAT, has developed a new strategy to generate timely national and international information about the products and processes within its remit, so that the regulator can identify problems affecting public health and propose appropriate actions1.
Argentina's Ministry of Health has recently stepped up its efforts to combat tropical diseases and cancer.